Consejo Nacional de Investigaciones Científicasy Técnicas (CONICET)/Centro de Estudios de Estadoy Sociedad (CEDES), Buenos Aires, Argentina,
Rev Panam Salud Publica. 2010 Oct;28(4):249-57. doi: 10.1590/s1020-49892010001000003.
to carry out a situational analysis of cervical cancer prevention activities in Argentina, specifically regarding (a) the organizational framework of cervical cancer prevention activities; (b) Pap-smear coverage; (c) cytology laboratory organization; and (d) follow-up/treatment of women with abnormal lesions.
a situational analysis of provincial cervical cancer programs using data from an ad-hoc questionnaire sent to the leaders of cervical cancer prevention programs in Argentina's 24 provinces. In addition, the provinces' program guidelines, statistical reports, laws, and program regulations were reviewed and certain key leaders were personally interviewed.
data were obtained for 19 of Argentina's 24 provinces. Four of the 19 provinces had no formal program framework. Conventional cytology was the most commonly used screening test. Screening was mainly opportunistic. The recommended interval between normal tests was 3 years in most provinces. The eligible age for screening ranged from 10-70 years of age; however, annual or biannual screening was the usual practice after becoming sexually active. None of the provincial programs had data available regarding Pap-smear coverage. Most of the cytology laboratories did not have a quality control policy. The number of smears read varied greatly by laboratory (650-24 000 per year). A log of events related to screening and treatment did not exist in most provinces.
screening in Argentina is mainly opportunistic, characterized by an estimated low coverage, coexisting with over-screening of women with access to health services, and an absence of quality control procedures. Policies for cervical cancer screening in the provinces vary and, most often, deviate from the national recommendation of one Pap smear every 3 years for women 35-64 years of age. Ensuring compliance with national program guidelines is an essential step toward significantly reducing the burden of cervical cancer.
对阿根廷的宫颈癌预防活动进行现状分析，具体涉及以下方面：（a）宫颈癌预防活动的组织框架；（b）巴氏涂片检查的覆盖率；（c）细胞学实验室的组织；以及（d）异常病变女性的随访/治疗。
通过向阿根廷 24 个省的宫颈癌防治项目负责人发送专门问卷，对省级宫颈癌项目进行现状分析。此外，还对各省的项目指南、统计报告、法律和项目法规进行了审查，并对部分关键领导人进行了个人访谈。
获得了阿根廷 24 个省中的 19 个省的数据。这 19 个省中有 4 个没有正式的项目框架。传统细胞学检查是最常用的筛查试验。筛查主要是机会性的。大多数省份建议的正常检查间隔为 3 年。筛查的合格年龄范围为 10-70 岁；然而，在开始性生活后，通常每年或每两年进行一次筛查。没有一个省级项目有巴氏涂片检查覆盖率的数据。大多数细胞学实验室没有质量控制政策。实验室每年阅读的涂片数量差异很大（650-24000 张）。大多数省份没有与筛查和治疗相关的事件记录。
阿根廷的筛查主要是机会性的，估计覆盖率较低，同时伴有获得卫生服务的女性过度筛查，且缺乏质量控制程序。各省的宫颈癌筛查政策各不相同，而且通常与国家建议的每 3 年对 35-64 岁女性进行一次巴氏涂片检查的建议不符。确保遵守国家项目指南是显著降低宫颈癌负担的重要步骤。
